Back

Ex vivo synergistic effects of apixaban with dual anti-platelet therapy (DAPT) in lowering platelet reactivity and thrombin generation (SEARCH)

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Thrombosis, Platelets, and Coagulation ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Ben Curry

MLM Medical Labs, Memphis (United States of America)

238 More presentations in this session

Presentation thumbnail
Prevalence of thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries and cryptogenic stroke
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
Doctor M. Centola (Desio, IT)
Abstract Slides
Presentation thumbnail
Clinical predictors and angiographic features of acute coronary syndromes caused by systemic embolism
Mr A. Jeronimo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Morphological characteristics of plaque erosion with noncritical coronary stenosis: an optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Metformin exerts cardioprotection via attenuating mitochondrial fission in cardiac ischaemia-reperfusion injury in rats
Doctor T. Priyadechawarawong (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources